Viridian Therapeutics, Inc. (VRDN)
32.29
-0.35
(-1.07%)
USD |
NASDAQ |
Jan 21, 16:00
32.18
-0.11
(-0.34%)
Pre-Market: 20:00
Viridian Therapeutics Free Cash Flow: -326.34M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Marker Therapeutics, Inc. | -14.82M |
| Orthofix Medical, Inc. | -3.353M |
| ADMA Biologics, Inc. | 40.61M |
| Avantor, Inc. | 523.60M |
| Immunovant, Inc. | -431.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -84.61M |
| Cash from Investing (Quarterly) | 126.08M |
| Cash from Financing (Quarterly) | 10.86M |
| Free Cash Flow Per Share (Quarterly) | -1.036 |
| Free Cash Flow to Equity (Quarterly) | -85.52M |
| Free Cash Flow to Firm (Quarterly) | -84.18M |
| Free Cash Flow Yield | -12.45% |